Test Price
5,000 AED✅ Home Collection Available
Genodermatoses Exome Sequencing Panel in UAE | 5000 AED | DHA Licensed
Executive Summary & Core Metrics
Executive Clinical Assurance
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing & Sanger confirmation.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (daily 8 AM – 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Interpretation & Specialist Guidance included.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731
Core Metrics
- Price: 5,000 AED
- Turnaround Time: 30 Working Days
- Sample Type: Peripheral Whole Blood
- Methodology: Next-Generation Sequencing (NGS) + Sanger Confirmation
Test Overview & Methodology
The Genodermatoses Exome Sequencing Panel decodes all protein-coding regions of genes linked to inherited skin disorders using Next-Generation Sequencing (NGS) with Sanger validation. This test outpaces conventional panels by detecting rare and novel variants specific to the UAE population, offering a comprehensive molecular diagnosis for suspected hereditary dermatological conditions.
| Feature | Our Exome Panel (ISO-Accredited) | Standard Gene Panel |
|---|---|---|
| Precision & Sensitivity | >99.9% analytical sensitivity; captures novel exons | Limited to pre-selected genes, may miss rare variants |
| Methodology | NGS + confirmatory Sanger sequencing | NGS only, often without orthogonal confirmation |
| Turnaround Time | 30 working days | 4–8 weeks, variable |
| UAE Compliance | DHA-licensed, home collection, PDPL-secure | Often no local regulatory oversight |
Physician Insight & Safety Protocols
“As a DHA-licensed Consultant Medical Geneticist, I emphasize that this comprehensive exome panel significantly enhances diagnostic yield for hereditary skin disorders, but results must be interpreted in the context of a thorough clinical dermatologic evaluation and family history. A negative result does not exclude all genetic causes; further testing or variant reclassification may be warranted over time.”
– Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
⚠️ Medication Advisory
Do not discontinue or alter any prescribed medication without consulting your doctor. Genetic findings may influence future therapy recommendations but should never replace immediate clinical decisions.
Exclusion Criteria & ER Red Flags
- Exclusion: Significant recent blood loss, active hemolysis, inability to provide informed consent per Federal Decree-Law No. 4 of 2016 on Medical Liability (Form 48 mandatory). Patients under 18 years require legal guardian consent.
- Seek Emergency Care if: Sudden widespread blistering, fever with skin rash, or signs of acute systemic genodermatosis – these require immediate dermatologic evaluation, not genetic testing.
Patient FAQ & Clinical Guidance
1. What is the Genodermatoses Exome Sequencing Panel, and who should consider it?
This panel analyzes all protein-coding genes associated with inherited skin disorders using next-generation sequencing. It is indicated for individuals with suspected genetic dermatoses, atypical presentations, a family history of hereditary skin conditions, or unexplained early-onset skin disease. Results can guide diagnosis, management, and familial risk assessment.
2. How long will I have to wait for results, and what do they mean?
Results are reported within 30 working days after sample receipt. A positive result identifies a pathogenic or likely pathogenic variant that may explain the condition. A negative result does not rule out a genetic cause, as new genes or variants are continuously discovered. Follow-up genetic counseling is recommended.
3. Is this test covered by my health insurance in the UAE?
We provide direct billing verification via WhatsApp to check if your insurance plan covers this genetic test. Many UAE insurance plans now include advanced genomic testing with a dermatologist’s referral. Contact +971 54 548 8731 for a rapid eligibility check.
UAE Regulatory & Data Privacy Adherence
Legal Compliance: This service operates under DHA Facility License No. 1143. All genetic data is handled in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing and consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Laboratory processes are ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139).
Physical Address: Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.
Clinical & Logistical Metadata
| Test Name | Genodermatoses Exome Sequencing Panel |
| Price (AED) | 5,000 |
| Turnaround Time | 30 Working Days |
| Sample Type / Matrix | Peripheral Whole Blood (VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection Available Daily 8 AM – 11 PM) |
| Methodology Used | Next-Generation Sequencing (NGS) with Sanger confirmation |
| ICD-10-CM Code | Z13.89 (Encounter for screening for other specified diseases) |
| LOINC Code | 94474-8 (Exome sequencing panel) |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians